(lp0
S'Simulations Plus Inc. SLP  Wall Street Journal - Feb 11, 2011 News Simulations Plus Inc.SLP. Significant News Only. 03/13/17; Press Release. Simulations Plus Reports Record Preliminary Revenues for Second Quarter FY2017.'
p1
aS'Trading Sheet: Watching the Numbers for Simulations Plus, Inc.  The Standard - 15 hours ago Looking at shares of Simulations Plus, Inc. , the company has an EV  of 184140. Enterprise Value is a measure of the total value of a specific company.'
p2
aS"Simulations Plus, Inc. Passes Its Checkup Seeking Alpha  - Jan 29, 2015 Simulations Plus  is a major software provider for pharmaceutical research and development. The company's software predictions reduce client's research and development costs and lead to faster conclusions. Revenues were up 54% over&nbsp;..."
p3
aS'Shorting Simulations Plus Is Silly Seeking Alpha - Feb 23, 2016 Simulations Plus  is my favorite buy-it-and-close-your-eyes-for-a-decade company, as I explained last week.'
p4
aS'Simulations Plus: Riding A 20% Plus Growth Industry Seeking Alpha  - Nov 4, 2014 The company operates in a drug simulation industry that is expected to grow more than 20% a year from now till 2020.'
p5
aS'Simulations Plus Reports Record Preliminary Revenues for Second Quarter FY2017 Business Wire  - Mar 13, 2017 LANCASTER, Calif.----Simulations Plus, Inc. , a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for the second quarter of its fiscal&nbsp;...'
p6
aS'Simulations Plus, Inc.  Files An 8-K Departure of Directors or ... Market Exclusive - Dec 1, 2016 Simulations Plus, Inc.  develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry.'
p7
aS'Simulations Plus Reports First Quarter FY2017 Financial Results Business Wire  - Jan 9, 2017 LANCASTER, Calif.----Simulations Plus, Inc. , the premier provider of simulation and modeling software and consulting services for all stages of pharmaceutical discovery and development from the earliest discovery through&nbsp;...'
p8
aS'Simulations Plus Inc : Financial Strength Analysis Simply Wall St - Jan 2, 2017 Including debt in the capital structure of companies such as Simulations Plus Inc , which has no debt, can improve its capital returns as the cost of capital comes down.'
p9
aS'Quarter 2017 Earnings Release and Conference Call Business Wire  - Jan 4, 2017 LANCASTER, Calif.----Simulations Plus, Inc.  announced today that it expects to file its quarterly report on Form 10-Q for the first quarter of its 2017 fiscal year on Monday, January 9, 2017.'
p10
a.